Publication Name	World Journal of Gastroenterology
Manuscript ID	5398
Country	South Korea

Received	2013-09-05 08:39
Peer-Review Started	2013-09-05 11:21
To Make the First Decision	2013-12-04 08:37
Return for Revision	2013-10-31 11:01
Revised	2013-10-17 21:33
Second Decision	2014-01-20 16:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-01-20 18:02
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-04-22 19:56
Publish the Manuscript Online	2014-05-14 10:58

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Attempts to enhance the eradication rate of Helicobacter pylori infection
Manuscript Source	Invited Manuscript
All Author List	Chang Seok Bang and Gwang Ho Baik
Funding Agency and Grant Number
Corresponding Author	Gwang Ho Baik, MD, Department of Internal Medicine, Hallym University College of Medicine, Kyo-dong, Chuncheon 200-704, South Korea. baikgh@hallym.or.kr
Key Words	Helicobacter pylori; Antimicrobial drug resistance; Clarithromycin; Metronidazole; Microbial sensitivity tests
Core Tip	There is no uniform and definite therapeutic regimen for the Helicobacter pylori (H. pylori) eradication currently. Increasing rates of antimicrobial resistance present challenges in maintaining optimal eradication rates. Knowledge of local antibiotic resistance and antibiotic consumption pattern is important in selecting a reliable regimen. In addition, adverse effect profiles of therapeutic regimens are important to enhance compliance rates. Bismuth-containing quadruple, sequential, concomitant, and levofloxacin-based triple therapies are replacing the long-standing standard of the triple regimen. Although various novel regimens and additive agents have indicated favorable outcomes, more studies or validations are needed to become a mainstream H. pylori therapy.
Publish Date	2014-05-14 10:58
Citation	Bang CS, Baik GH. Attempts to enhance the eradication rate of Helicobacter pylori infection. World J Gastroenterol 2014; 20(18): 5252-5262
URL	http://www.wjgnet.com/1007-9327/full/v20/i18/5252.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i18.5252

Full Article (PDF)	WJG-20-5252.pdf
Full Article (Word)	WJG-20-5252.doc
Manuscript File	5398-Review.doc
Answering Reviewers	5398-Answering reviewers.pdf
Copyright License Agreement	5398-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	5398-Language certificate.pdf
Peer-review Report	5398-Peer reiew(s).pdf
Scientific Editor Work List	5398-Scientific editor work list.doc